Proapoptotic action of p53-Tom5 in p53-resistant A549 human nonsmall cell lung cancer cells through direct mitochondrial dysfunction

5Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Transcription-dependent apoptosis triggered by p53 hardly occurs in alternative reading frame (ARF)-null cancer cells. Loss of ARF leads to hyperactivation of murine double minute 2 (MDM2), resulting in the degradation of p53. In the present study, A549 (ARF-null) human non-small lung cancer cells were transfected with a plasmid DNA encoding human wild-type p53 and the mitochondrial transmembrane domain of Tom5 (p53-Tom5) for delivering p53 to mitochondria. As a result, p53-Tom5 exclusively localized at mitochondria in A549 cells and suppressed the proliferation of them, whereas wild-type p53 did not. In addition, mitochondrial dysfunction and release of cytochrome c were induced by p53-Tom5 in A549 cells. These data suggest that p53-Tom5 suppressed the proliferation of A549 cells through direct mitochondrial dysfunction. © 2011 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Umemoto, T., Asai, T., Hirashima, K., Shimizu, K., Mihara, M., Yamamoto, K., … Oku, N. (2011). Proapoptotic action of p53-Tom5 in p53-resistant A549 human nonsmall cell lung cancer cells through direct mitochondrial dysfunction. Biological and Pharmaceutical Bulletin, 34(4), 551–554. https://doi.org/10.1248/bpb.34.551

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free